• Belinostat (PXD101): Reading Drug Response

  2026-09-08

  Belinostat (PXD101) is a pan-HDAC inhibitor whose effects can reflect both proliferation arrest and cell death. This guide connects its epigenetic mechanism with a more rigorous assay strategy for interpreting bladder and prostate cancer models.

• Fe3O4@ZIF-8 Nanoparticles in Jaw Osteomyelitis

  2026-09-08

  The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a dual-function platform for treating jaw osteomyelitis. pH-responsive Zn2+ release provides antibacterial activity, while liberated magnetic Fe3O4 nanoparticles, combined with a static magnetic field, support repair of infected bone defects.

• DIDS: Practical Workflows for Channel and Tumor Assays

  2026-09-07

  DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) connects chloride transport assays with mechanistic studies of near-death tumor cells, vascular tone, TRPV1 signaling, and neuroprotection. This guide emphasizes formulation control, concentration selection, matched controls, and interpretation limits so researchers can use DIDS without mistaking broad transport effects for pathway-specific biology.

• VX-765 Workflows for Caspase-1 Research

  2026-09-07

  Build cleaner inflammation experiments with VX-765 by connecting caspase-1 activity to cytokine release, pyroptosis, barrier permeability, and immune-cell trafficking. This workflow-oriented guide covers formulation, assay design, BBB applications, and troubleshooting for translational research.

• A40926: Dalbavancin Precursor and Cell-Wall Target

  2026-09-05

  A40926 is a natural glycopeptide antibiotic and dalbavancin precursor that targets D-alanyl-D-alanine termini in bacterial peptidoglycan precursors. Its reported activity against Gram-positive organisms, MRSA, and Neisseria gonorrhoeae supports applications in bacterial cell wall synthesis and antibiotic-resistance research.

• Resiniferatoxin (RTX): Pain Model Workflows

  2026-09-04

  Resiniferatoxin (RTX) delivers exceptionally strong, selective TRPV1 activation for studying calcium influx, sensory-neuron desensitization, and durable analgesia. This practical guide connects route selection, calcium-imaging workflows, pain-model endpoints, and cholesterol-depletion strategies for better experimental control.

• DOT1L Inhibition as a Renal Fibrosis Mechanism

  2026-09-04

  The reference study identifies DOT1L-dependent H3K79 methylation as a modifiable regulator of renal fibroblast activation and epithelial–mesenchymal transition in obstructive kidney injury. Its combined animal, cell-based, and genetic evidence supports DOT1L inhibition as a mechanistic research strategy for studying renal fibrosis, while also defining important limits for translation beyond the tested models.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-09-03

  The 2024 Autophagy study identifies a double-positive feedback loop linking AMPK and SQSTM1/p62 during metabolic stress. This circuit coordinates lysosomal signaling, KEAP1 degradation, NRF2 activation, and antioxidant adaptation, providing a mechanistic framework for understanding stress resilience in STK11- and KEAP1-altered lung cancer.

• Nadolol (SQ-11725) Experimental Workflows

  2026-09-03

  Nadolol (SQ-11725) enables controlled perturbation of non-selective beta-adrenergic signaling in cardiovascular cell, tissue, and pharmacokinetic studies. This workflow-focused guide combines receptor-pathway assays with transporter-aware exposure checks, helping researchers distinguish pharmacology from distribution effects.

• Coumestrol: ER Antagonism Meets Ferroptosis

  2026-09-02

  Coumestrol is a phytoestrogen estrogen receptor antagonist that connects nuclear receptor pharmacology with ferroptosis research in rheumatoid arthritis synoviocytes. This article presents a mechanism-centered framework for interpreting concentration, mitochondrial, and PMAIP1-dependent assay data.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-09-02

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, or otherwise difficult DNA templates where standard Taq-based workflows may be inadequate. It is appropriate for blunt-ended products used in cloning and sequencing, but should not be selected when 3′-A overhangs or sticky-end ligation products are required.

• Capsazepine: An Assay Logic for TRPV1 Studies

  2026-09-01

  Capsazepine is a TRPV1 ion channel antagonist that can help separate sensory transduction from broader inflammatory and affective responses. This guide combines channel pharmacology with insights from a recent cannabidiol pain study to improve assay interpretation, controls, and translational restraint.

• Dabigatran Etexilate as an Oral Direct Thrombin Inhibitor

  2026-09-01

  The reference review presents dabigatran etexilate as the first marketed oral direct thrombin inhibitor, emphasizing its rapid, predictable anticoagulant activity and oral alternative to vitamin K antagonists and low-molecular-weight heparins. Its evidence synthesis connects prodrug activation, pharmacokinetics, coagulation assays, clinical efficacy, bleeding risk, and renal function to the practical design of anticoagulation research.

• Amorolfine Hydrochloride and the Integrity Frontier

  2026-08-31

  A systems-level perspective on how Amorolfine Hydrochloride can support fungal cell membrane disruption studies, connect membrane biology with ploidy limits, and strengthen translational antifungal research.

• Carbenoxolone disodium: Lab Workflow Guide

  2026-08-31

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best suited to cell- and tissue-based mechanistic workflows, not in vivo efficacy studies or experiments requiring a highly selective single-target probe.

8095 records 3/540 page Previous Next 12345 下5页 Last page